Dr Richard W. Barker was Director General of the Association of the British Pharmaceutical Industry from August 2004 to May 2011.
The problem of counterfeit medicines has always been a concern. Bona fide medicines quite rightly go through rigorous testing every step of the way to ensure that patient safety is protected. And the supply chain from manufacturers through to wholesalers, pharmacists, and doctors is a carefully regulated one.Read more
Russell Brown’s letter to Andrew Lansley and Nicola Sturgeon calling for action to tackle medicines supply shortages is welcome. The Association of the British Pharmaceutical Industry has been calling for a solution too.Read more
The ABPI is seeking clarification from the Department of Health on the future of the Earlier Access Scheme.Read more